<!doctype html>
<html lang="en">
<head>
  <meta charset="utf-8" />
  <meta name="viewport" content="width=device-width, initial-scale=1" />
  <title>Pleural effusion — DGRefHelp Drafts</title>
  <link rel="stylesheet" href="../assets/site.css" />
</head>
<body>
  <div class="container">
    <div class="header">
      <div class="brand">
        <h1><a href="../index.html">DGRefHelp drafts</a> / Pleural effusion</h1>
        <div class="sub">CXR-confirmed pleural effusion: assess severity and red flags, do safe baseline tests, and route to same-day assessment / pleural clinic / suspected cancer pathway as appropriate.</div>
      </div>
      <div class="badges">
        <div class="badge">Mode: quick</div>
        <div class="badge">Last updated: 2026‑02‑10</div>
      </div>
    </div>

    <div class="grid">
      <div class="card">
        <div class="card-hd">
          <div class="tabs" data-tabs>
            <button class="tab" role="tab" data-tab="evidence" aria-selected="true">Evidence</button>
            <button class="tab" role="tab" data-tab="draft" aria-selected="false">DGRefHelp draft</button>
            <button class="tab" role="tab" data-tab="refs" aria-selected="false">References</button>
          </div>
          <div class="copybar">
            <button class="btn" data-copy-target="#draftText">Copy draft</button>
            <button class="btn" data-copy-target="#evidenceText">Copy evidence</button>
          </div>
        </div>

        <div class="card-bd">
          <div class="panel active" role="tabpanel" data-panel="evidence">
            <div id="evidenceText" class="section">
              <h3>Evidence summary (triangulated)</h3>

              <div class="callout ok">
                <strong>Key design points</strong>
                <ul>
                  <li>In primary care, pleural effusion work is mostly <strong>triage + safe baseline assessment</strong>; definitive investigation (usually <strong>ultrasound-guided aspiration</strong> with pleural fluid analysis and targeted imaging) sits in secondary care pleural services.</li>
                  <li>First decide: <strong>unstable / very symptomatic?</strong> (hypoxia, significant respiratory distress, sepsis) → <strong>same-day hospital assessment</strong>.</li>
                  <li>An <strong>unexplained unilateral pleural effusion</strong> should be treated as potentially serious until proven otherwise (malignancy, pleural infection, PE, TB) and routed for prompt specialist assessment.</li>
                  <li>NICE NG12 includes pleural-disease signals for <strong>mesothelioma</strong> (urgent CXR for adults ≥40 with chest signs compatible with pleural disease; suspected cancer pathway referral if CXR suggests mesothelioma).</li>
                </ul>
              </div>

              <div class="callout warn">
                <strong>Local-process sensitivity</strong>
                <ul>
                  <li>Routes vary: SDEC/acute medicine vs respiratory/pleural clinic vs radiology “direct to USS + aspiration”.</li>
                  <li>Access to same-day CXR, urgent ultrasound, and who can aspirate pleural fluid differs by health board.</li>
                  <li>This page is drafted to be safe even if the D&amp;G routing is not yet agreed; see the <strong>Local agreement needed</strong> checklist.</li>
                </ul>
              </div>

              <h4>Comparator sources used for the draft</h4>
              <ul>
                <li>NICE NG12 (Suspected cancer: recognition and referral): lung and pleural cancers section (mesothelioma: urgent CXR criteria; suspected cancer pathway referral for CXR suggesting mesothelioma).</li>
                <li>British Thoracic Society (BTS) Pleural Disease Guideline (2023): pleural disease guidance including investigation/management pathways for undiagnosed unilateral pleural effusion (high-level principles used; local implementation varies).</li>
              </ul>

              <div class="callout">
                <strong>Scope note</strong>
                <div class="small">This is a <em>primary care</em> triage/referral draft. It is not a pleural-procedures guide.</div>
              </div>
            </div>
          </div>

          <div class="panel" role="tabpanel" data-panel="draft">
            <div id="draftText" class="section">
              <h3>Pleural effusion — adults (primary care triage)</h3>

              <h4>Definition / scope</h4>
              <ul>
                <li><strong>Pleural effusion</strong> = abnormal fluid in the pleural space (usually detected on CXR/ultrasound).</li>
                <li>Applies to adults. Separate pathways needed for children, pregnancy, and significant immunocompromise.</li>
                <li>Assumes effusion is suspected clinically and/or seen on imaging; if not yet imaged, start with <strong>CXR</strong> (and consider same-day assessment if unwell).</li>
              </ul>

              <h4>Immediate red flags (send same day: ED / SDEC / acute assessment)</h4>
              <ul>
                <li><strong>Respiratory compromise:</strong> severe breathlessness, exhaustion, cyanosis, <strong>SpO2 low on air</strong>, new confusion.</li>
                <li><strong>Sepsis / pleural infection concern:</strong> fever, rigors, pleuritic chest pain, toxic appearance, rising inflammatory markers (if available), or CXR suggesting <strong>parapneumonic effusion/empyema</strong>.</li>
                <li><strong>Haemodynamic instability</strong> or syncope.</li>
                <li><strong>Massive effusion</strong> with significant symptoms or mediastinal shift on imaging (if reported).</li>
                <li><strong>Possible PE with instability</strong> (pleuritic pain + breathlessness ± haemoptysis ± collapse).</li>
              </ul>

              <h4>Step 1 — confirm + characterise (what you can safely do in primary care)</h4>
              <ul>
                <li><strong>CXR</strong>: confirm effusion; note unilateral vs bilateral; any mass/pleural thickening/collapse/consolidation.</li>
                <li><strong>Observations:</strong> HR, BP, RR, Temp, <strong>SpO2 on air</strong>.</li>
                <li><strong>History:</strong>
                  <ul>
                    <li>Time course; pleuritic pain; cough/fever; weight loss/night sweats; haemoptysis.</li>
                    <li>Heart failure features (orthopnoea/PND, ankle oedema).</li>
                    <li>VTE risk factors (recent surgery/immobility, previous VTE, malignancy, oestrogen therapy).</li>
                    <li>TB risk (exposure, travel, immunosuppression).</li>
                    <li>Asbestos exposure (mesothelioma risk).</li>
                  </ul>
                </li>
                <li><strong>Examination:</strong> reduced chest expansion, reduced breath sounds, stony dullness; signs of HF; lymphadenopathy.</li>
              </ul>

              <h4>Step 2 — baseline tests (before referral, if stable and this doesn’t delay)</h4>
              <ul>
                <li><strong>Bloods (suggested):</strong> FBC, U&amp;E, LFT, CRP (if infection suspected).</li>
                <li><strong>Consider</strong> NT‑proBNP if HF is plausible and diagnosis uncertain (local availability).</li>
                <li><strong>Do not delay</strong> same-day assessment for bloods if the patient is significantly symptomatic/unwell.</li>
              </ul>

              <h4>Step 3 — likely cause patterns (to guide routing)</h4>
              <ul>
                <li><strong>Heart failure</strong> (often bilateral): dyspnoea, oedema, raised JVP, cardiomegaly; consider HF workup and treatment; refer/admit if new severe HF or hypoxia.</li>
                <li><strong>Parapneumonic effusion / empyema</strong>: febrile, pleuritic pain, pneumonia features; needs same-day assessment for antibiotics +/- drainage.</li>
                <li><strong>Malignancy</strong> (often unilateral): weight loss, persistent symptoms, haemoptysis, pleural thickening, large recurrent effusion; prompt pleural/resp assessment.</li>
                <li><strong>PE</strong>: pleuritic pain + breathlessness; may have small effusion; follow suspected PE pathway (local).</li>
                <li><strong>TB</strong>: systemic symptoms + risk factors; pleural effusion can be a presenting feature; needs specialist assessment and microbiology liaison.</li>
              </ul>

              <h4>Who to refer / where to send</h4>
              <ul>
                <li><strong>Same-day hospital assessment (ED/SDEC)</strong> for: red flags above, suspected empyema/parapneumonic effusion, hypoxia, severe symptoms, or diagnostic uncertainty in a sick patient.</li>
                <li><strong>Respiratory / pleural service</strong> (urgent) for:
                  <ul>
                    <li><strong>Unexplained unilateral effusion</strong> (especially if new),</li>
                    <li>effusion with <strong>pleural thickening</strong> or suspicious CXR features,</li>
                    <li>recurrent effusion, or</li>
                    <li>effusion where aspiration/biopsy is likely needed (most unilateral effusions).</li>
                  </ul>
                </li>
                <li><strong>Suspected cancer pathway referral</strong> (lung/pleural; urgent) if:
                  <ul>
                    <li>CXR has findings that suggest <strong>mesothelioma</strong> (NICE NG12), or</li>
                    <li>CXR is otherwise suspicious for lung/pleural malignancy (local pathway).</li>
                  </ul>
                </li>
              </ul>

              <h4>What to include in the referral</h4>
              <ul>
                <li>Symptoms and timeline; pleuritic pain; fever; weight loss/night sweats; haemoptysis.</li>
                <li>Smoking and asbestos exposure history (if known).</li>
                <li>VTE risk factors and PE features (if present).</li>
                <li>Observations incl. <strong>SpO2 on air</strong>.</li>
                <li>CXR report (attach/copy); baseline bloods (if done).</li>
              </ul>

              <h4>Safety-netting</h4>
              <ul>
                <li>Seek urgent care if worsening breathlessness, chest pain, fever/rigors, haemoptysis, syncope, or SpO2 drops.</li>
                <li>If managed as HF in community, arrange close follow-up and reassess if not improving promptly.</li>
              </ul>

              <h4>Local agreement needed (D&amp;G)</h4>
              <ul>
                <li><label><input type="checkbox" /> What is the default route for a <strong>new unilateral pleural effusion</strong> seen on CXR (respiratory/pleural clinic vs SDEC vs direct radiology pathway)?</label></li>
                <li><label><input type="checkbox" /> Is there a <strong>same-day</strong> route for large/symptomatic effusions (SDEC/acute medicine) and what are the acceptance criteria?</label></li>
                <li><label><input type="checkbox" /> Who arranges <strong>urgent pleural ultrasound</strong> and <strong>diagnostic aspiration</strong> (pleural team vs radiology), and what referral details are required?</label></li>
                <li><label><input type="checkbox" /> Preferred baseline tests before referral (e.g. FBC/U&amp;E/LFT/CRP ± NT‑proBNP) and where they should be available (GP vs hospital).</label></li>
                <li><label><input type="checkbox" /> Suspected cancer pathway: local triggers for <strong>lung/pleural</strong> referral when effusion is present (and whether CXR report wording matters).</label></li>
              </ul>

              <div class="callout warn">
                <strong>Reminder</strong>
                <div class="small">Do not attempt pleural aspiration in primary care unless you are trained, equipped, and working in an appropriate environment with imaging guidance and monitoring.</div>
              </div>
            </div>
          </div>

          <div class="panel" role="tabpanel" data-panel="refs">
            <div class="section">
              <h3>References</h3>
              <ul>
                <li>NICE. <em>Suspected cancer: recognition and referral (NG12)</em>. Lung and pleural cancers (mesothelioma): urgent chest X‑ray criteria; suspected cancer pathway referral if CXR suggests mesothelioma. Accessed 2026‑02‑10. https://www.nice.org.uk/guidance/ng12/chapter/Recommendations-organised-by-site-of-cancer</li>
                <li>British Thoracic Society (BTS). <em>Pleural Disease guideline</em> (July 2023) — includes guidance for undiagnosed unilateral pleural effusion and related pleural conditions. Accessed 2026‑02‑10. https://www.brit-thoracic.org.uk/quality-improvement/guidelines/pleural-disease/</li>
              </ul>
            </div>
          </div>

        </div>
      </div>
    </div>
  </div>

  <script src="../assets/site.js"></script>
</body>
</html>
